• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

Technologies.org

Technology Trends: Follow the Money

  • Technology Events 2022-2023
  • Sponsored Post
    • Make a Contribution
  • Technology Markets
    • Venture Capital
  • About
  • Contact

Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test

June 9, 2020 By admin Leave a Comment

Illumina, Inc. (NASDAQ: ILMN) is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Illumina COVIDSeq™ Test, a high-throughput, sequencing-based, in vitro diagnostic (IVD) workflow enabling the detection of SARS-CoV-2. The end-to-end workflow extends the options available for labs to scale diagnostic testing.

COVIDSeq uses upper respiratory specimens, including a nasopharyngeal or oropharyngeal swab, and delivers sample receipt to result in 24 hours using the NovaSeq™ 6000 Sequencing System. The differentiated diagnostic design includes 98 amplicons that target the full SARS-CoV-2 genome, creating accurate detection and high sensitivity. COVIDSeq is currently available to a limited number of early access sites, and is expected to be more broadly available this summer.

The workflow accommodates up to 3,072 samples per NovaSeq run leveraging the S4 flow cell, and includes steps for viral RNA extraction, RNA-to-CDNA conversion, PCR, library preparation, sequencing and report generation. The key components leveraged include the NovaSeq 6000, coupled with Illumina Tagmentation library preparation technology, and the DRAGEN™ COVIDSeq Test Pipeline for rapid reporting.

“COVIDSeq leverages the performance of NGS to help address the global need for diagnostic testing to fight the COVID-19 pandemic,” said Francis deSouza, Chief Executive Officer of Illumina. “Beyond diagnostic testing, Illumina and a number of our customers are exploring NGS-based workflows to enable high-volume screening to support a return to work and school.”

COVIDSeq has not been FDA cleared or approved. This test is authorized by FDA under an EUA for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19. COVIDSeq is only authorized for use in laboratories in the U.S., certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform moderate and high complexity tests. Outside the U.S., COVIDSeq will be labeled either as Research Use Only (RUO), or with labeling aligned with local regulations.

For additional information, please visit www.illumina.com/covidseq

About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com

Filed Under: Tech

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Market Analysis

Blue hydrogen becoming increasingly cost competitive
The U.S. is behind China on hypersonic weapon technology
Immersive Virtual
DeFiRetailing.com (DeFi Retailing): DeFi will change retail as we know it
Indonesia has the fastest-growing population of smartphone users in the world
Australia approves a drought-tolerant genetically modified strain of wheat for use in food
The U.S.’s blood supply had dipped to levels that the Red Cross has not seen in 10 years

Market Research Media

Top technology, media, and telecommunications (TMT) companies for total shareholder return (TSR)
New skills will be required for the future world of work
Gaming-Disorder.com: Gaming disorder is now recognised by the World Health Organisation
Military Applications of Extended Reality
Worldwide government IT spending is forecast to total $565.7 billion in 2022, an increase of 5% from 2021
ReleaseWealth.com (Release Wealth): Modern Philanthropy is Technology-Based
MktForecast.com: Market Forecast Methodology

Secondary Sidebar

Tech Events

Fiber Connect 2021, July 25-28, Gaylord Opryland Resort & Convention Center, Nashville, Tennessee
The global State of Open Data Policy Summit takes place on Tuesday, 17 May from 17 CET!
SIGGRAPH 2022, 8–11 August 2022, Vancouver
Tableau Conference 2022, In person + virtual, May 17–19, 2022, Las Vegas
K-Global 2021, November 8-10, 2021

Venture Capital

Upcoming Technology Conferences
AI21 Labs Raises $64 Million to Change the Way People Read and Write Using Artificial Intelligence
Epirus Raises $200 Million in Series C Funding
SoftBank will be cutting its startup investments by 50-75% through March 2023
Konnecto Raises $21M to establish a new category in marketing technology

Footer

Recent Posts

  • Williams Invests in Technology to Generate Zero-Emission Hydrogen with Natural Gas
  • Nuclear power is overall one of the least deadly sources of energy
  • Postal Service Modernization Enables Expanded Electric Vehicle Opportunity
  • Toshiba Materials in Major Investment to Increase Silicon Nitride Ball Production Capacity
  • Ravn Alaska Orders 30 Hydrogen-Electric Engines from ZeroAvia
  • Sisvel Launches a Patent Pool on Wi-Fi 6
  • U.S. solar manufacturing missing a window of opportunity
  • General Atomics Advances Fusion Technology with Silicon Carbide (SiC)–Based Materials
  • Berge Bulk vessels to receive Anemoi Rotor Sails in its move towards a zero-emission fleet
  • BIRD – Israel-U.S. Binational Industrial R&D Foundation to invest $7.9 million in 9 new projects: The approved projects, with an overall budget of $20 million, involve innovations in the areas of Drones, Energy Efficiency, Environment Protection, Medical Devices, Pharma, Software and AI

App Coding

security-as-code integrated with dev tools
Scrub your code in real-time
Platform.sh Secures $140 million in Series D Funding to Support Enterprises in Scaling Fleets of Websites and Applications
Distraction-free coding
Code Intelligence raises $12M Series A

API Coding

DataGrail Launches API & Agent to Automate DSR Fulfillment Across All Internal Data Systems, Saving Companies Weeks of Engineering Time
Most commonly used HTTP Headers
Fintech AI Leader Photon Commerce Partners With Identifee to Enable Banks to Instantly Digitize and Analyze Statements
Types of API Testing
Difference between REST and GraphQL

Blockchaining

Bit.Store Platform Launches Social-Fi Collaborative Investment
One of the world’s biggest blockchains is testing a new way to approve transactions
Fairmint Launches the First Solution Enabling Community Ownership Through Equity Tokenization
SuperTeam Games Raises $10 Million to Create Sports Games Enhanced by Blockchain Technology
Direct and indirect dependencies created by software reuse

Event Calendar

NAB Show Express Receives High Engagement With 40,000 Participants Worldwide
Ministry of Environment to Hold Online Environmental Exhibition “Virtual Japan Pavilion – Innovation for 2050 Net-zero”, March 3 – 23, 2021
Guadalajara International Book Fair (La Feria Internacional del Libro de Guadalajara, better known as FIL), November 28 – December 6, 2020
Financial crime compliance professionals to converge at the ACAMS24+ Global Virtual Summit on June 2, 2020
retailX 2021 conference and exhibition, August 24-25, 2021, McCormick Place Convention Center, Chicago

Copyright © 2022 Technologies.org

Market Analysis & Market Research

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT